AVITA Medical announces distribution agreement to expand to Australia and New Zealand

Latest News

AVITA Medical (ASX:AVH) has announced it has entered into an exclusive distribution agreement with Revolution Surgical to expand into the Australian and New Zealand markets.

Under the terms of the agreement, Revolution Surgical will serve as the exclusive distributor of the RECELL product platform, including RECELL GO, pending regulatory approval, in Australia and New Zealand.

The RECELL System treats thermal burn wounds and full-thickness skin defects.

"Our collaboration with Revolution Surgical marks the return of RECELL to Australia," said Jim Corbett, CEO of AVITA Medical. "Originally developed in Australia, RECELL has since revolutionised burn care in the U.S. This agreement reintroduces our innovative technology to its place of origin and further demonstrates our commitment to improving patient outcomes, now in Australia and New Zealand."